Skip to main content
OpenTrials
Completed

NCT Number: NCT06706024

Effect of a Breathing Exercise in Patients Under Hemodialysis

Purpose: To examine the effects of breathing exercises on respiratory functions and 6 Minute Walk Test (6 WT) distance in patients receiving hemodialysis treatment.

Method: This is a quasi-experimental study with a single group pretest-posttest design. It was conducted with 30 individuals in the hemodialysis unit of a public hospital between July 2022 and October 2022. Data were also collected before starting the intervention (week 1) and after completing the intervention (week 8). Socio-Demographic Data Survey, 6 Minute Walk Test and Respiratory Function Test were used as data collection tools and data were collected face to face. In the analysis of the data, mean, standard deviation, percentage, t test in dependent groups, and Wilcoxon analysis were used.

KeyWords: Individuals receiving hemodialysis treatment, respiratory exercise program, nursing care

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–84 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Çankiri Karatekin University

Çankırı, Ori̇ji̇n, 18100, Turkey (Türkiye)

About this study

Creating and Implementing an Exercise Program Data were collected before starting the intervention (1st week) and after the intervention was completed (8th week). 6 Minute Walking Test and Respiratory Function Test were applied to the patients before the implementation of the exercise program and after 8 weeks of application. According to the results of the Pulmonary Function Test evaluated by the pulmonologist, COPD is in Grades 3 and 4. Stage 1 patients were not included in the study. A practical explanation was given about how to use the flow-oriented Intensive Spirometry Device (ICC) (Triflow) after the 3rd hour of the treatment in the HD unit. Each of the patients was given the same brand and model flow-focused intensive spirometer (Triflow) device for breathing exercise. The Triflow device has three compartments with a capacity of 1200 ml, with a ball of different colors in each compartment. The Triflow device is based on the patient taking a maximal inspiration, then holding the breath for as long as he can (at least 5 seconds), and then exhaling slowly. The patient watches the movement of the balls for visual feedback.

During Triflow use, patients were placed in a sitting position. They were told to hold the device in an upright position, put the mouthpiece of the Triflow in their mouth, completely cover the mouthpiece with their lips to prevent air from escaping, take a deep and slow breath after a quiet exhalation, increase the duration of holding their breath as much as the patient can tolerate, and then release the balls by exhaling. Patients were instructed to bring their devices with them to each session. Since some patients forgot their hemodialysis unit and exercise device and stated that they had difficulty in bringing them back and forth due to the long distance between the dialysis unit and home, each patient was given a special triflo device to be kept in the hemodialysis unit, separate from the ones they use at home.

The exercise program was performed 3 times a week for 8 weeks, under the supervision of the researcher, with 10 repetitions at the 3rd and 4th hours of the dialysis treatment. It was recommended that they do 10 repetitions every hour after waking up on days when there was no dialysis session. In the study, patients adhered to the breathing exercise program, and no problems were reported regarding device use during the session or at home.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being ≥18 years old;
  • Receiving HD treatment three times a week for at least 3 months;
  • Not having a condition that prevents walking;

Exclusion criteria

  • Having a history of Myocardial Infarction or Anginapectoris within the last month,
  • Uncontrolled arrhythmia and heart rate >120/min,
  • Having uncontrolled hypertension (BP>180/100 mm-Hg),
  • Having a history of cerebrovascular accident
  • Having advanced stage COPD (Stage 3, Stage 4) and advanced Stage Heart Failure (Stage 3/Stage 4),
  • Having profound anemia (Hb<7 g/dl),
  • Having a history of blood transfusion in the last month,
  • Having an active and chronic infection (Tuberculosis, osteomyelitis, rheumatoid arthritis),
  • Needing additional oxygen therapy,
  • Hospitalization in the last 1 month,
  • Patients with physical or mental health problems that would prevent communication were not included in the study.

Treatment and study plan

Breathing exercise

Other

Patients Under Hemodialysis

Other names: 6 minute walking test

Primary outcomes

  1. Respiratory Function Test- FVC

    Time frame: 0- 8. weeks

    Forced Vital Capacity (FVC): The amount of air that is exhaled forcefully and rapidly after taking as much breath as possible.

  2. Respiratory Function Test- FEV1

    Time frame: 0- 8. weeks

    1st Second Forced Expiratory Volume (FEV1): The amount of air exhaled in the first second of the FVC test.

  3. Respiratory Function Test- FEF

    Time frame: 0- 8. weeks

    Forced Expiratory Flow (FEF): The average flow rate during the middle half of the FVC test.

  4. Respiratory Function Test- PEFR

    Time frame: 0- 8. weeks

    Peak Expiratory Flow Rate (PEFR): The maximum airflow rate achieved during a forced exhalation.

Sponsors and collaborators

Lead sponsor

Çankırı Karatekin University

Other

Registry information

Official study title

Effect of a Breathing Exercise on Respiratory Function and 6-Minute Walking Distance in Patients Under Hemodialysis

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Nov 26, 2024
Registry last updated
Nov 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.